Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrudential Regulatory News (PRU)

Share Price Information for Prudential (PRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 756.20
Bid: 754.80
Ask: 755.20
Change: 27.60 (3.79%)
Spread: 0.40 (0.053%)
Open: 736.00
High: 756.40
Low: 732.80
Prev. Close: 728.60
PRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of $1bn 2.95% subordinated notes

27 Oct 2021 15:21

RNS Number : 4738Q
Prudential PLC
27 October 2021
 

 

Prudential plc

 

Successful pricing of US$1,000,000,000 2.95 per cent. Subordinated Notes due 3 November 2033 by Prudential plc ("Prudential")

 

Further to the announcement of 25 October 2021, Prudential today announces that it has successfully priced US$1,000,000,000 2.95 per cent. Subordinated Notes due 3 November 2033 (the "Notes") to be issued pursuant to Prudential's US$10,000,000,000 Medium Term Note Programme.

 

A summary of the principal terms of the Notes is set out below for the purposes of information only, and will be qualified by the more detailed information to be contained in the Final Terms relating to the Notes (the "Final Terms"), which will be made available in due course, and should be read in conjunction with the prospectus dated 21 September 2021 relating to Prudential's US$10,000,000,000 Medium Term Note Programme (the "Prospectus").

 

· Issuer: Prudential plc

· Issue date: 3 November 2021 (the "Issue Date")

· Maturity date: 3 November 2033

· Aggregate nominal amount: US$ 1,000,000,000

· Rate of interest: 2.95 per cent. per annum payable semi-annually in arrear, subject to reset on the seventh anniversary of the Issue Date (as defined above)

· Ratings: A- (S&P) / A3 (Moody's)

· Listing / trading venue: FCA Official List / London Stock Exchange's Regulated Market

· Capital qualification: Intended to qualify as Tier 2 group capital of Prudential under the Insurance (Group Capital) Rules of Hong Kong (Cap. 41O of the Laws of Hong Kong).

 

As announced on 25 October 2021, the expected use of proceeds of the issuance is general corporate purposes including the planned redemption of Prudential's US$725 million 4.375 per cent. Undated Tier 2 Notes (ISIN: XS1488414464).

 

This announcement is not provided for, or directed at, persons in the United States.

 

Enquiries to:

 

Media:

Investors/Analysts:

Addy FrederickPing Ping Tan

+44 (0)20 3977 9399 +65 9845 8904

Patrick BowesWilliam Elderkin

+44 (0)20 3977 9702+44 (0)20 3977 9215

About Prudential plc

 

Prudential provides life and health insurance and asset management, with a focus on Asia and Africa. The business helps people get the most out of life, by making healthcare affordable and accessible and by promoting financial inclusion. Prudential protects people's wealth, helps them grow their assets, and empowers them to save for their goals. The business has more than 17 million life customers in Asia and Africa and is listed on stock exchanges in London, Hong Kong, Singapore and New York. Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

 

Disclaimer

 

Please note that the information contained in the Prospectus and the Final Terms (once published) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus and the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus and the Final Terms whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement.

 

Nothing in this announcement, and neither the Prospectus nor the Final Terms, constitutes an offer of securities for sale in the United States. The securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.

 

Forward-looking statements

 

This announcement may contain "forward-looking statements" with respect to certain of Prudential plc ("Prudential")'s plans and its goals and expectations relating to the proposed redemption of certain debt securities and its future financial condition, performance, results, strategy and objectives. Statements that are not historical facts, including statements about Prudential's beliefs and expectations and including, without limitation, statements containing the words "may", "will", "should", "continue", "aims", "estimates", "projects", "believes", "intends", "expects", "plans", "seeks" and "anticipates", and words of similar meaning, are forward-looking statements. These statements are based on plans, estimates and projections as at the time they are made, and therefore undue reliance should not be placed on them. By their nature, all forward-looking statements involve risk and uncertainty.

 

A number of important factors could cause Prudential's actual future financial condition or performance or other indicated results of the entity referred to in any forward-looking statement to differ materially from those indicated in such forward-looking statement. Such factors include, but are not limited to, the impact of the current Covid-19 pandemic, including adverse financial market and liquidity impacts, responses and actions taken by governments, regulators and supervisors, the impact to sales, claims and assumptions and increased product lapses, disruption to Prudential's operations (and those of its suppliers and partners), risks associated with new sales processes and information security risks; future market conditions, including fluctuations in interest rates and exchange rates, the potential for a sustained low-interest rate environment, and the impact of economic uncertainty, asset valuation impacts from the transition to a lower carbon economy, derivative instruments not effectively hedging exposures arising from product guarantees, inflation, including interest rate rises as a response, and deflation and the performance of financial markets generally; global political uncertainties, including the potential for increased friction in cross-border trade and the exercise of executive powers to restrict trade, financial transactions, capital movements and/or investment; the policies and actions of regulatory authorities, including, in particular, the policies and actions of the Hong Kong Insurance Authority, as Prudential's Group-wide supervisor, as well as new government initiatives generally; given its designation as an Internationally Active Insurance Group, the impact on Prudential of systemic risk and other group supervision policy standards adopted by the International Association of Insurance Supervisors; the impact of competition and fast-paced technological change; the effect on Prudential's business and results from, in particular, mortality and morbidity trends, lapse rates and policy renewal rates; the physical, social and financial impacts of climate change and global health crises on Prudential's business and operations; the timing, impact and other uncertainties of future acquisitions or combinations within relevant industries; the impact of internal transformation projects and other strategic actions failing to meet their objectives; the effectiveness of reinsurance for Prudential's businesses; the risk that Prudential's operational resilience (or that of its suppliers and partners) may prove to be inadequate, including in relation to operational disruption due to external events; disruption to the availability, confidentiality or integrity of Prudential's information technology, digital systems and data (or those of its suppliers and partners); any ongoing impact on Prudential of the demerger of M&G plc and the demerger of Jackson Financial Inc.; the impact of changes in capital, solvency standards, accounting standards or relevant regulatory frameworks, and tax and other legislation and regulations in the jurisdictions in which Prudential and its affiliates operate; the impact of legal and regulatory actions, investigations and disputes; and the impact of not adequately responding to environmental, social and governance issues. These and other important factors may, for example, result in changes to assumptions used for determining results of operations or re-estimations of reserves for future policy benefits. Further discussion of these and other important factors that could cause Prudential's actual future financial condition or performance or other indicated results of the entity referred to in any forward-looking statements to differ, possibly materially, from those anticipated in Prudential's forward-looking statements can be found under the 'Risk Factors' heading in Prudential's 2021 Half Year Report and the 'Risk Factors' heading of Prudential's most recent Half Year Report on Form 6-K filed with the U.S. Securities and Exchange Commission ("SEC"). Prudential's most recent Half Year Report and Form 6-K are available on its website at www.prudentialplc.com.

 

Any forward-looking statements contained in this announcement speak only as of the date on which they are made. Each of Prudential and its Representatives expressly disclaims any obligation to update any of the forward-looking statements contained in this announcement or any other forward-looking statements it may make, whether as a result of future events, new information or otherwise except as required pursuant to the UK Prospectus Rules, the UK Listing Rules, the UK Disclosure Guidance and Transparency Rules, the Hong Kong Listing Rules, the SGX-ST listing rules or other applicable laws and regulations.

 

Prudential may also make or disclose written and/or oral forward-looking statements in reports filed with or furnished to the Financial Conduct Authority, the SEC or other regulatory authorities, as well as in its annual report and accounts to shareholders, periodic financial reports to shareholders, proxy statements, offering circulars, registration statements, prospectuses and prospectus supplements, press releases and other written materials and in oral statements made by directors, officers or employees of Prudential to third parties, including financial analysts. All such forward-looking statements are qualified in their entirety by reference to the factors discussed under the 'Risk Factors' heading in Prudential's 2021 Half Year Report and the 'Risk Factors' heading of Prudential's most recent Half Year Report on Form 6-K filed with the SEC. These factors are not exhaustive as Prudential operates in a continually changing business environment with new risks emerging from time to time that it may be unable to predict or that it currently does not expect to have a material adverse effect on its business.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLSITLDFIL
Date   Source Headline
3rd May 20243:55 pmRNSDirector/PDMR Shareholding
2nd May 20249:56 amRNSDividend Rate Achieved
30th Apr 20249:29 amRNSTotal Voting Rights
30th Apr 20249:26 amRNSEMTN: Publication of a Prospectus
30th Apr 20247:00 amRNSPrudential Plc - 1Q24 Business Performance Update
22nd Apr 20248:34 amRNSNotice of AGM
18th Apr 20249:00 amRNSBLOCK LISTING APPLICATION
12th Apr 202410:01 amRNSDirector/PDMR Shareholding
28th Mar 20241:44 pmRNSDirector/PDMR Shareholding
28th Mar 20249:37 amRNSTotal Voting Rights
27th Mar 20242:34 pmRNSDirector/PDMR Shareholding
27th Mar 20242:28 pmRNSDirector/PDMR Shareholding
27th Mar 202410:08 amRNSOverseas Regulatory Announcement - Grant of Awards
26th Mar 20242:41 pmRNSAnnual Report and Accounts 2023 and Form 20-F
20th Mar 202411:33 amRNSDividend Declaration
20th Mar 202411:33 amRNSPrudential plc – FY23 Results – Additional Info
20th Mar 202411:33 amRNSPrudential plc – FY23 Results – EEV
20th Mar 20248:10 amRNSDividend Declaration
20th Mar 20248:09 amRNSPrudential plc – FY23 Results – Additional Info
20th Mar 20248:08 amRNSPrudential plc – FY23 Results – EEV
20th Mar 20248:03 amRNSPrudential plc – FY23 Results – IFRS
12th Mar 20249:52 amRNSDirector/PDMR Shareholding
29th Feb 202411:08 amRNSTotal Voting Rights
14th Feb 20248:47 amRNSDirector/PDMR Shareholding
31st Jan 20248:53 amRNSTotal Voting Rights
25th Jan 20249:02 amRNSBoard changes
16th Jan 20246:02 pmRNSCompletion of Share Repurchase Programme
16th Jan 20245:56 pmRNSTransaction in Own Shares
15th Jan 20245:45 pmRNSTransaction in Own Shares
12th Jan 20245:49 pmRNSTransaction in Own Shares
11th Jan 20246:04 pmRNSTransaction in Own Shares
11th Jan 20249:53 amRNSDirector/PDMR Shareholding
10th Jan 20246:07 pmRNSTransaction in Own Shares
9th Jan 20245:49 pmRNSTransaction in Own Shares
8th Jan 20245:58 pmRNSTransaction in Own Shares
5th Jan 20248:35 amRNSRepurchase to neutralise share scheme issuance
29th Dec 20238:47 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSPrudential & CITIC provide growth capital for CPL
14th Dec 202310:37 amRNSDirector/PDMR Shareholding
12th Dec 202310:04 amRNSDirector/PDMR Shareholding
30th Nov 202311:54 amRNSTotal Voting Rights
30th Nov 202311:47 amRNSBLOCK LISTING SIX MONTHLY RETURN
16th Nov 20239:17 amRNSBLOCK LISTING APPLICATION
14th Nov 20238:47 amRNSDirector/PDMR Shareholding
6th Nov 20237:19 amRNSPrudential plc - Q3 Business Performance Update
31st Oct 20239:12 amRNSTotal Voting Rights
30th Oct 202311:27 amRNSDirector/PDMR Shareholding
12th Oct 20239:49 amRNSDirector/PDMR Shareholding
9th Oct 20239:44 amRNSDividend Rate Achieved
3rd Oct 202310:31 amRNSOverseas Regulatory Announcement-Grant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.